ID: ALA141460

Max Phase: Preclinical

Molecular Formula: C23H27N5O3S

Molecular Weight: 453.57

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(C/N=C(/S)N2CCN(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1

Standard InChI:  InChI=1S/C23H27N5O3S/c1-29-17-6-4-16(5-7-17)14-24-23(32)28-10-8-27(9-11-28)22-18-12-20(30-2)21(31-3)13-19(18)25-15-26-22/h4-7,12-13,15H,8-11,14H2,1-3H3,(H,24,32)

Standard InChI Key:  SCGYVNOQVNQTNY-UHFFFAOYSA-N

Associated Targets(Human)

Platelet-derived growth factor receptor 507 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 453.57Molecular Weight (Monoisotopic): 453.1835AlogP: 3.26#Rotatable Bonds: 6
Polar Surface Area: 72.31Molecular Species: ZWITTERIONHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.01CX Basic pKa: 13.61CX LogP: 4.47CX LogD: 4.46
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.35Np Likeness Score: -0.90

References

1. Matsuno K, Nakajima T, Ichimura M, Giese NA, Yu JC, Lokker NA, Ushiki J, Ide S, Oda S, Nomoto Y..  (2002)  Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.,  45  (20): [PMID:12238930] [10.1021/jm0201114]

Source